Medicated Skin Care in the US

Euromonitor International's Medicated Skin Care in the US report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

• Get a detailed picture of the medicated skin care industry
• Identify factors driving change
• Understand the competitive environment, the market's major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

• Medicated Skin Care in the US
• Euromonitor International
• March 2009
• Executive Summary
• OTC Industry Proves Recession Resistant
• Fusion of Standard and Herbal Medicine Emerges
• Private Label Gains Share
• Retailers Focus on Consumer Health
• Industry Growth Is Expected To Remain Dynamic
• Key Trends and Developments
• America Is Becoming Less Healthy
• Fusion of Standard and Natural Medicine
• Behind-the-counter Category Emerges
• US Economic Slowdown Promotes Self-medication
• Private Label Proves To Be A Tenacious Competitor
• Vitamins and Dietary Supplements Registration and Classification
• Self-medication and Preventative Medicine
• Generics
• Switches
• Market Indicators
• Market Data
• Definitions
• Adams Respiratory Therapeutics Inc
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Bayer Corp
• Strategic Direction
• Key Facts
• Company Background
• Competitive Positioning
• Chattem Inc
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• General Nutrition Centers Inc
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• GlaxoSmithKline Consumer Health
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Johnson & Johnson Inc
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Mannatech Inc
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Melaleuca Inc
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Procter & Gamble Co, the
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Wyeth Consumer Healthcare Inc
• Strategic Direction
• Key Facts
• Company Background
• Production
• Competitive Positioning
• Headlines
• Trends
• Switches
• Competitive Landscape
• Prospects
• Sector Data
• List of Summaries
  • Summary 1 OTC Healthcare Switches 2005-2007
  • Summary 2 Research Sources
  • Summary 3 Adams Respiratory Therapeutics Inc: Key Facts
  • Summary 4 Adams Respiratory Therapeutics Inc: Competitive Position 2008
  • Summary 5 Bayer Corp: Key Facts
  • Summary 6 Bayer Corp: Competitive Position 2008
  • Summary 7 Chattem Inc: Key Facts
  • Summary 8 Chattem Inc: Operational Indicators
  • Summary 9 Chattem Inc: Competitive Position 2008
  • Summary 10 General Nutrition Centers Inc: Key Facts
  • Summary 11 General Nutrition Centers Inc: Operational Indicators
  • Summary 12 General Nutrition Centers Inc: Competitive Position 2008
  • Summary 13 GlaxoSmithKline: Key Facts
  • Summary 14 GlaxoSmithKline: Competitive Position 2008
  • Summary 15 Johnson & Johnson Inc: Key Facts
  • Summary 16 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2008
  • Summary 17 Pfizer Consumer Healthcare Ltd: Competitive Position 2008
  • Summary 18 Johnson & Johnson Consumer Products Inc: Competitive Position 2008
  • Summary 19 Advanced Care Products: Competitive Position 2008
  • Summary 20 Neutrogena: Competitive Position 2008
  • Summary 21 Mannatech Inc: Key Facts
  • Summary 22 Mannatech Inc: Operational Indicators
  • Summary 23 Mannatech Inc: Competitive Position 2008
  • Summary 24 Melaleuca Inc: Key Facts
  • Summary 25 Melaleuca Inc: Operational Indicators
  • Summary 26 Melaleuca Inc: Competitive Position 2008
  • Summary 27 Procter & Gamble: Key Facts
  • Summary 28 Procter & Gamble: Competitive Position 2008
  • Summary 29 Wyeth Consumer Healthcare: Key Facts
  • Summary 30 Wyeth Consumer Healthcare: Operational Indicators
  • Summary 31 Wyeth Consumer Healthcare: Competitive Position 2008
• List of Tables
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
  • Table 2 Life Expectancy at Birth 2003-2008
  • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
  • Table 5 OTC Healthcare Company Shares by Value 2004-2008
  • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
  • Table 7 Penetration of Private Label by Sector 2003-2008
  • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
  • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
  • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
  • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
  • Table 12 Sales of Medicated Skin Care by Subsector: Value 2003-2008
  • Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
  • Table 14 Herbal vs Standard Medicated Skin Care 2003-2008
  • Table 15 Acne Treatments by Format: % Value Breakdown 2004-2008
  • Table 16 Medicated Skin Care Company Shares by Value 2004-2008
  • Table 17 Medicated Skin Care Brand Shares by Value 2005-2008
  • Table 18 Acne Treatments Brand Shares by Value 2005-2008
  • Table 19 Hair Loss Treatments Brand Shares by Value 2005-2008
  • Table 20 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
  • Table 21 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013